Mexico Huntingtons Disease Treatment Market Size & Outlook
Mexico huntingtons disease treatment market, 2018-2030 (US$M)
Related Markets
Mexico huntingtons disease treatment market highlights
- The Mexico huntingtons disease treatment market generated a revenue of USD 1.3 million in 2023 and is expected to reach USD 9.9 million by 2030.
- The Mexico market is expected to grow at a CAGR of 34% from 2024 to 2030.
- In terms of segment, symptomatic treatment was the largest revenue generating treatment in 2023.
- Symptomatic Treatment is the most lucrative treatment segment registering the fastest growth during the forecast period.
Huntingtons disease treatment market data book summary
| Market revenue in 2023 | USD 1.3 million |
| Market revenue in 2030 | USD 9.9 million |
| Growth rate | 34% (CAGR from 2023 to 2030) |
| Largest segment | Symptomatic treatment |
| Fastest growing segment | Symptomatic Treatment |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Symptomatic Treatment |
Other key industry trends
- In terms of revenue, Mexico accounted for 0.3% of the global huntingtons disease treatment market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil huntingtons disease treatment market is projected to lead the regional market in terms of revenue in 2030.
- Argentina is the fastest growing regional market in Latin America and is projected to reach USD 4.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Huntingtons Disease Treatment Market Scope
Huntingtons Disease Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Mexico huntingtons disease treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to huntingtons disease treatment market will help companies and investors design strategic landscapes.
Symptomatic treatment was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Mexico huntingtons disease treatment market based on symptomatic treatment covering the revenue growth of each sub-segment from 2018 to 2030.
Typical antipsychotics are more widely utilized in Mexico than atypical antipsychotics for symptom management in case of HD. Haloperidol is the most commonly prescribed medication, accounting for 42.2% of overall prescriptions for HD treatment.
Other medications, such as tetrabenazine, which may be used less frequently, accounted for around 9.2% of prescriptions for a variety of reasons, including cost. Furthermore, Mexico has higher healthcare expenditure than other countries in Latin America. In 2018, Mexico’s healthcare expenditure per capita was USD 520.
In addition, a report suggests that the Mexican government spent around 5.37% of the GDP on hospital and outpatient care sector in 2018. These factors are expected to fuel growth of Huntington’s disease treatment market over the forecast period.
Reasons to subscribe to Mexico huntingtons disease treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Mexico huntingtons disease treatment market databook
-
Our clientele includes a mix of huntingtons disease treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico huntingtons disease treatment market , including forecasts for subscribers. This country databook contains high-level insights into Mexico huntingtons disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Mexico huntingtons disease treatment market size, by treatment, 2018-2030 (US$M)
Mexico Huntingtons Disease Treatment Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
